Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Feb 13, 2024

SELL
$272.48 - $330.23 $1.2 Million - $1.45 Million
-4,400 Reduced 9.52%
41,816 $12.1 Million
Q2 2023

Aug 08, 2023

SELL
$272.48 - $330.23 $1.2 Million - $1.45 Million
-4,400 Reduced 9.52%
41,816 $12.1 Million
Q1 2023

Feb 13, 2024

SELL
$276.36 - $326.03 $831,843 - $981,350
-3,010 Reduced 6.11%
46,216 $14.7 Million
Q1 2023

May 11, 2023

SELL
$276.36 - $326.03 $831,843 - $981,350
-3,010 Reduced 6.11%
46,216 $14.7 Million
Q4 2022

Feb 13, 2024

SELL
$212.22 - $313.46 $675,920 - $998,370
-3,185 Reduced 6.08%
49,226 $14.5 Million
Q4 2022

Feb 09, 2023

SELL
$212.22 - $313.46 $675,920 - $998,370
-3,185 Reduced 6.08%
49,226 $14.5 Million
Q2 2022

Feb 13, 2024

BUY
$186.4 - $279.02 $2.29 Million - $3.42 Million
12,275 Added 30.58%
52,411 $11.4 Million
Q2 2022

Jul 26, 2022

BUY
$186.4 - $279.02 $2.29 Million - $3.42 Million
12,275 Added 30.58%
52,411 $11.4 Million
Q1 2022

Feb 13, 2024

BUY
$194.8 - $275.7 $7.82 Million - $11.1 Million
40,136 New
40,136 $10.7 Million
Q1 2022

May 11, 2022

BUY
$194.8 - $275.7 $1.39 Million - $1.97 Million
7,146 Added 21.66%
40,136 $10.7 Million
Q4 2021

Feb 11, 2022

SELL
$255.32 - $318.29 $1,276 - $1,591
-5 Reduced 0.02%
32,990 $8.78 Million
Q3 2021

Nov 15, 2021

SELL
$260.36 - $307.27 $1,301 - $1,536
-5 Reduced 0.02%
32,995 $9.38 Million
Q2 2021

Aug 12, 2021

SELL
$225.52 - $304.06 $1,127 - $1,520
-5 Reduced 0.02%
33,000 $9.06 Million
Q1 2021

May 14, 2021

SELL
$235.95 - $293.05 $154,547 - $191,947
-655 Reduced 1.95%
33,005 $8.61 Million
Q4 2020

Feb 10, 2021

BUY
$215.97 - $265.89 $60,471 - $74,449
280 Added 0.84%
33,660 $8.61 Million
Q3 2020

Nov 13, 2020

BUY
$192.55 - $236.59 $6.43 Million - $7.9 Million
33,380 New
33,380 $7.9 Million

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $18.4B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Nicholas Company, Inc. Portfolio

Follow Nicholas Company, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Company, Inc. with notifications on news.